The Wilms Tumor-1 (WT1) rs16754 polymorphism is a prognostic factor in acute myeloid leukemia (AML): a meta-analysis

about

The Wilms Tumor-1 (WT1) rs16754 polymorphism is a prognostic factor in acute myeloid leukemia (AML): a meta-analysis

Item

http://www.wikidata.org/entity/Q37362606

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Wilms Tumor-1 (WT1) rs1675 ...... eukemia (AML): a meta-analysis

@en

The Wilms Tumor-1

@nl

type

Item

label

The Wilms Tumor-1 (WT1) rs1675 ...... eukemia (AML): a meta-analysis

@en

The Wilms Tumor-1

@nl

prefLabel

The Wilms Tumor-1 (WT1) rs1675 ...... eukemia (AML): a meta-analysis

@en

The Wilms Tumor-1

@nl

P1476

The Wilms Tumor-1 (WT1) rs1675 ...... eukemia (AML): a meta-analysis

@en

P2093

Jianting Long

http://www.w3.org/2001/XMLSchema#string

Qiangsheng Dai

http://www.w3.org/2001/XMLSchema#string

Shenming Wang

http://www.w3.org/2001/XMLSchema#string

Shi Fang

http://www.w3.org/2001/XMLSchema#string

Wanshou Zhu

http://www.w3.org/2001/XMLSchema#string

Xiaolian Liu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia

WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group

Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.

Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation.

EWS-WT1 oncoprotein activates neuronal reprogramming factor ASCL1 and promotes neural differentiation.

WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors.

P304

32079-32087

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.18632/ONCOTARGET.8117

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2016-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26992216

http://www.w3.org/2001/XMLSchema#string

P921

acute myeloid leukemia

genetic variation

neoplasm proteins

P932

5077998

http://www.w3.org/2001/XMLSchema#string